Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Lithuanian Ambassador to the United Kingdom, His Excellency Mr Eitvydas Bajarūnas, paid a visit to Professor Skirmantas Kriaučionis of the Ludwig Institute for Cancer Research at the Nuffield Department of Medicine.

Eitvydas Bajarūnas, the Lithuanian Ambassador to the United Kingdom, and First Secretaries Gitana Šukaitytė and Tadas Kubilius visited Nuffield Department of Medicine’s Ludwig Oxford branch last week and met with group leader Prof Skirmantas Kriaučionis to discuss his work on DNA modifications in cancer.

Prof Skirmantas, whose interest in scientific research began in his native Lithuania, received a prestigious award from the Lithuanian Ministry of Education and Science following his discovery of the modified DNA base, 5-hydroxymethylcytosine. This award is given to prominent Lithuanian scientists working abroad in physics, biomedical sciences and technology, and encourages collaborative links with scientific and academic communities in Lithuania.

Following the meeting, Prof Skirmantas said: “This was an exciting opportunity to discuss avenues for future interaction, including incentives for talented Lithuanian students to come to study in Oxford and ways to facilitate collaborations between life science academics in the UK and Lithuania. Based on our respective experiences in different countries, we discussed success stories in Sweden and the US, such as promoting a culture of entrepreneurship in different sectors and nurturing philanthropies for science funding.”

Commenting on the visit, Ambassador Bajarūnas said: “It is a great pleasure to hear about the important work being carried out by the Ludwig Institute at the University of Oxford by Skirmantas and his colleagues. Future challenges in cancer research will undoubtedly require international collaborations, and we will continue to give our full support to partnerships between the UK and Lithuanian life sciences communities.”

You can learn more about work in the Kriaučionis lab here.

Similar stories

Benemérita Universidad Autónoma de Puebla representatives visit Jenner Institute

Academic representatives from Benemérita Universidad Autónoma de Puebla (BUAP), one of the leading universities in Mexico, paid a visit to NDM’s Jenner Institute.

RECOVERY trial team wins the MRC Impact Prize

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Continued support to CPM helps it explore personalised medicine

The Dr Stanley Ho Medical Development Foundation will continue its funding support for The Centre for Personalised Medicine (CPM) for further seven years.

Shifting the needle: finding solutions for rare diseases

Rare diseases are a global health challenge. To address this, organisations around the world, including the Nuffield Department of Medicine (NDM), are working together to find solutions for patients.

Coronavirus Vaccines Research and Development Roadmap launched

The Coronavirus Vaccines Research and Development Roadmap is a comprehensive plan to galvanize a global effort to protect the world from this large and dangerous family of viruses.

Multidisciplinary dengue forecasting project launches in Vietnam

DART (Dengue Advanced Readiness Tools), is a new project supported by Wellcome to use climate data to better predict and prepare for infectious diseases outbreaks.